Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 9

1.

The human decatenation checkpoint.

Deming PB, Cistulli CA, Zhao H, Graves PR, Piwnica-Worms H, Paules RS, Downes CS, Kaufmann WK.

Proc Natl Acad Sci U S A. 2001 Oct 9;98(21):12044-9. Epub 2001 Oct 2.

2.

Replication checkpoint: preventing mitotic catastrophe.

Canman CE.

Curr Biol. 2001 Feb 20;11(4):R121-4. Review.

3.

Human topoisomerase II function, tyrosine phosphorylation and cell cycle checkpoints.

Kaufmann WK.

Proc Soc Exp Biol Med. 1998 Mar;217(3):327-34. Review.

PMID:
9492343
4.

Evidence that the ATR/Chk1 pathway maintains normal replication fork progression during unperturbed S phase.

Petermann E, Caldecott KW.

Cell Cycle. 2006 Oct;5(19):2203-9. Epub 2006 Oct 1. Review.

PMID:
16969104
5.

Mechanisms of ATR-mediated checkpoint signalling.

Smits VA, Warmerdam DO, Martin Y, Freire R.

Front Biosci (Landmark Ed). 2010 Jun 1;15:840-53. Review.

PMID:
20515729
6.

[Cell cycle, mitosis and therapeutic applications].

Levy A, Albiges-Sauvin L, Massard C, Soria JC, Deutsch E.

Bull Cancer. 2011 Oct;98(9):1037-45. doi: 10.1684/bdc.2011.1381. Review. French.

7.

Checking on DNA damage in S phase.

Bartek J, Lukas C, Lukas J.

Nat Rev Mol Cell Biol. 2004 Oct;5(10):792-804. Review.

PMID:
15459660
8.

Small Molecules Targeting Ataxia Telangiectasia and Rad3-Related (ATR) Kinase: An Emerging way to Enhance Existing Cancer Therapy.

Andrs M, Korabecny J, Nepovimova E, Jun D, Hodny Z, Kuca K.

Curr Cancer Drug Targets. 2016;16(3):200-8. Review.

PMID:
26882028
9.

BRIT1/MCPH1: a guardian of genome and an enemy of tumors.

Chaplet M, Rai R, Jackson-Bernitsas D, Li K, Lin SY.

Cell Cycle. 2006 Nov;5(22):2579-83. Epub 2006 Nov 15. Review.

PMID:
17172830

Supplemental Content

Support Center